Ethics of modifying the mitochondrial genome

Journal of Medical Ethics

Volumn 37, Issue 2, 2011, Pages 97-100

  Bredenoord, A L ^a   Dondorp, W ^a   Pennings, G ^b   De Wert, G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; BIOETHICS; CELL NUCLEUS TRANSPLANTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ETHICS; FEMALE; GENETIC ENGINEERING; GENETICS; HUMAN; MALE; MITOCHONDRIAL GENOME; PREGNANCY;

BIOETHICAL ISSUES; DNA, MITOCHONDRIAL; FEMALE; GENETIC ENGINEERING; GENOME, MITOCHONDRIAL; HUMANS; MALE; MITOCHONDRIAL DISEASES; NUCLEAR TRANSFER TECHNIQUES; PREGNANCY;

EID: 79151475787     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/jme.2010.037481     Document Type: Article

References (35)

1. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005;6:389-402.
2. De Wert G. Human cloning: the case of the (preimplantation) embryo, and ethical exploration. In: Gunning J, ed. Assisted conception. Research ethics and law. Aldershot: Ashgate Darthmouth, 2000:83-107.
3. Brown DT, Herbert M, Lamb VK, et al. Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet 2006;368:87-9.
4. Roberts RM. Prevention of human mitochondrial (mtDNA) disease by nucleus transplantation into an enucleated donor oocyte. Am J Med Genet 1999;87:265-6.
5. Bredenoord AL, Pennings G, de Wert G. Ooplasmic transfer and nuclear transfer to prevent mitochondrial DNA disorders: conceptual and normative issues. Hum Reprod Update 2008;14:669-78.
6. Tachibana M, Sparman M, Sritanaudomchai H, et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009;461:367-72.
7. Craven L, Tuppen HA, Greggains GD, et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010;465:82-5.
8. Bredenoord AL, Pennings G, Smeets HJ, et al. Dealing with uncertainties. Ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update 2008;14:83-94.
9. Bredenoord AL, Dondorp W, Pennings G, et al. PGD to reduce reproductive risk: the case of mitochondrial DNA disorders. Hum Reprod 2008;23:2392-401.
10. Council of Europe. Convention for Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Biomedicine: Convention of Human Rights and Biomedicine. Kennedy Institute Ethics Journal 1997;7:277-90.
11. Feinberg J. The child's right to an open future. In: Aiken W, LaFolette H, eds. Whose child? Children's rights, parental authority, and state power. Totowa NJ: Rowman and Littlefield, 1980.
12. Chapman AR, Frankel MS, eds. Designing Our Descendants. The Promise and Perils of Genetic Modification. Baltimore and London: The Johns Hopkins University Press, 2003.
13. Baruch S, Huang A, Pritchard D, et al. Human Germline Genetic Modification: Issues and Options for Policymakers. Washington, DC: Genetics and Public Policy Center, 2005.
14. Rubenstein DS, Thomasma DC, Schon EA, et al. Germ-line therapy to cure mitochondrial disease: protocol and ethics of in vitro ovum nuclear transplantation. Cambr Q Healthc Ethics 1995;4:316-39.
15. Sato A, Kono T, Nakada K, et al. Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation. Proc Natl Acad Sci U S A 2005;102:16765-70.
16. Human Fertilization and Embryology Authority RO153. http://www.hfea.gov.uk./docs/R0153_How_the_decision_was_made_to_licence_this_research_project__2_.pdf (accessed 25 Oct 2010).
17. Roubertoux PL, Sluyter F, Carlier M, et al. Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice. Nat Genet 2003;35:65-9.
18. Moreno-Loshuertos R, Acin-Perez R, Fernandez-Silva P, et al. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 2006;38:1261-8.
19. Nagao Y, Totsuka Y, Atomi Y, et al. Decreased physical performance of congenic mice with mismatch between the nuclear and the mitochondrial genome. Genes Genet Syst 1997;73:21-7.
20. Thorburn DR, Dahl HH, Singh KK. The pros and cons of mitochondrial manipulation in the human germ line. Mitochondrion 2001;1:123-7.
21. Bonnicksen AL. The politics of germline therapy. Nat Genet 1998;19:10-11.
22. Bowles EJ, Campbell KH, St John JC. Nuclear transfer: preservation of a nuclear genome at the expense of its associated mtDNA genome(s). Curr Top Dev Biol 2007;77:268-84.
23. St John JC, Lloyd REI, Bowles EJ, et al. The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective. Reproduction 2004;127:631-41.
24. Poulton J, Kennedy S, Oakeshott P, et al. Nuclear transfer to prevent mitochondrial DNA diseases. Lancet 2006;368:841.
25. Szebik I. Altering the mitochondrial genome: is it just a technical issue? Response to 'germ line therapy to cure mitochondrial disease: protocol and ethics of in vitro ovum nuclear transplantation'. Cambr Q Healthc Ethics 1999;8:369-74.
26. Parens E, Juengst E. Inadvertently crossing the germ line. Science 2001;292:397.
27. Ossorio PN. Inheritable genetic modifications: do we owe them to our children? In: Chapman AR, Frankel MS, eds. Designing our descendants. The promise and perils of genetic modification. Baltimore and London: Johns Hopkins University Press, 2003:252-71.
28. Parfit D. Reasons and Persons. Oxford: Oxford University Press, 1984.
29. DeGrazia D. Human Identity and Bioethics. Cambridge: Cambridge University Press, 2005.
30. Habermas J. The Future of Human Nature. Cambridge: Polity Press, 2003.
31. Dekker TJ. The illiberality of perfectionist enhancement. Med Health Care Philos 2009;12:91-8.
32. Buchanan A, Brock DW, Daniels N, et al. From Chance to Choice. Genetics and Justice. Cambridge: Cambridge University Press, 2000.
33. Glover J. Choosing Children. Genes, Disability, and Design. Oxford: Clarendon Press, 2006.
34. Bredenoord AL, Van der Graaf R, Van Delden JJM. Towards a "post-posthuman dignity area" in evaluating emerging enhancement technologies. Am J Bioeth 2010;10:55-7.
35. Bredenoord AL, Dondorp WJ, Pennings G, et al. Avoiding transgenerational health risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? Human Reprod 2010;25:1354-60.